Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Conditions: Leukemia - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Fludarabine Phosphate and Total-Body Irradiation Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Lymphoblastic Leukemia in Remission - Chronic Myelogenous Leukemia, BCR-ABL1 Positive - Chronic Phase Chronic Myelogenous Leukemia - Philadelphi
3 Locations available
- Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;
2 Locations available
- T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Disease - Leukemia, Lymphocytic, Chronic - Lymphoproliferative Disorders
1 Location available
- HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Myelodysplasia - Chronic Myeloid Leukemia - Histiocytosis
1 Location available
- Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
Conditions: Juvenile Myelomonocytic Leukemia
1 Location available
- Allogeneic Transplantation Using TL1 & ATG for Older Patients With Hematologic Malignancies
Conditions: Blood Cancer - Leukemia
1 Location available
- Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome - Chronic Myelomonocytic Leukemia
1 Location available
- LMB-2 to Treat Hairy Cell Leukemia
Conditions: Positive Hairy Cell Leukemia - CD25-Expressing Hairy Cell Leukemia
1 Location available
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leuk
3 Locations available
- Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloprolife
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
Conditions: Chronic Myelogenous Leukemia - Acute Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome
1 Location available
- Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Conditions: Relapsed Acute Leukemia - Refractory Acute Leukemia
1 Location available
- All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab
Conditions: Acute Promyelocytic Leukemia
1 Location available
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lym
Conditions: Leukemia - Lymphoma
1 Location available
- Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
1 Location available
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Kidney Cancer - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Pulmonary Complications - Sarcoma
38 Locations available
- PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
137 Locations available
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphob
Conditions: Kidney Cancer - Leukemia - Lymphoma - Neurotoxicity - Peripheral Neuropathy - Sarcoma
44 Locations available
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
153 Locations available
- Hyper-CVAD Plus Dasatinib in Philadelphia/BCR-ABL Positive ALL
Conditions: Acute Lymphoblastic Leukemia - Leukemia
1 Location available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
172 Locations available
- Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hem
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
Conditions: Leukemia
1 Location available
- Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Conditions: Acute Promyelocytic Leukemia
2 Locations available
- Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Flu
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
4 Locations available
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycop
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
1 Location available
- Stem Cell Transplantation for Hematological Malignancies
Conditions: Leukemia, Lymphocytic, Acute - AML - MDS
1 Location available
- Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic - AML - Leukemia, Lymphocytic, Acute - MDS - Leukemia, Lymphocytic, Chronic - JMML - Hodgkin's Disease - Non-hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Study of Dasatinib in Patients With Chronic Myelogenous Leukemia
Conditions: Chronic Myelogenous Leukemia
1 Location available
- Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
4 Locations available
- Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Conditions: Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions: Leukemia
70 Locations available
- Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Cyclophosphamide, Fludarabine, Total-Body Irradiation, and Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer or Other
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes
1 Location available
- Treatment of Acute Lymphoblastic Leukemia in Children
Conditions: Drug/Agent Toxicity by Tissue/Organ - Leukemia
6 Locations available
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer o
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
1 Location available
- Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
Conditions: Chronic Lymphocytic Leukemia (CLL)
2 Locations available
- ALL Adult Consortium Trial: Adult ALL Trial
Conditions: Acute Lymphoblastic Leukemia
4 Locations available
- Genetic Study of Chronic Lymphocytic Leukemia Families
Conditions: Leukemia
1 Location available
- Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
Conditions: Leukemia
4 Locations available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia
1 Location available
- Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remissio
Conditions: Leukemia
20 Locations available
- Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic - Lymphomas - Multiple Myeloma - Myelodysplastic Syndrome - Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - AML
1 Location available
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors - Malignant Melanoma - Hematological Malignancies - Myelogenous Leukemia, Chronic - Leukemia, Lymphoblastic, Acute
1 Location available
- Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myeloge
Conditions: Leukemia
1 Location available
- Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
64 Locations available
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficienc
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
2 Locations available
- DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
3 Locations available
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine
Conditions: Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
4 Locations available
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies - Acute Myeloid Leukemia - Lymphoid Leukemia - Chronic Myeloid Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndromes
12 Locations available
- Low Dose IL-2 for GVHD as GVHD Prophylaxis After Stem Cell Transplantation
Conditions: Leukemia - Lymphoma
2 Locations available
- Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
Conditions: Leukemia
4 Locations available
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL) - Leukemia, Myeloid, Acute(AML) - Leukemia, Myeloid, Chronic(CML) - Juvenile Myelomonocytic Leukemia (JMML) - Hemoglobinuria, Paroxysmal Nocturnal (PNH) - Hodgkin Lymphoma - Lymphoma, Non-Hodgkin (NHL) - Myelodysplastic S
1 Location available
- CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion
Conditions: Leukemia - Bone Marrow Transplantation - Immunodeficiencies
1 Location available
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Conditions: Lymphoma - Leukemia - Multiple Myeloma - Colon Cancer - Renal Cancer
1 Location available
- Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Conditions: Leukemia - Solid Tumors
1 Location available
- Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
Conditions: Leukemia
1 Location available
- Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Fludarabine, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk C
Conditions: B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia - T-cell Large Granular Lymphocyte Leukemia
2 Locations available
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Pati
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Undifferentiated Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myel
1 Location available
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
120 Locations available
- UCN-01 and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndr
Conditions: Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Leukemia - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
5 Locations available
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinic
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Adults - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Metastatic Cancer - Neurofibromatosis Type
1 Location available
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed
Conditions: Leukemia
48 Locations available
- T-Reg Cell Kinetics for Patients Receiving Stem Cell Transplant
Conditions: Leukemia - Hodgkin Lymphoma - Non Hodgkin Lymphoma - Myelodysplastic Disease - Myeloproliferative Disorders
3 Locations available
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Conditions: Leukemia, Myelogenous, Chronic - Leukemia, Lymphoblastic, Acute - Leukemia, Myelogenous, Acute - Myeloproliferative-Myelodysplastic Diseases - Lymphoma, Malignant
1 Location available
- Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia
1 Location available
- Genetic Epidemiology of Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin - Leukemia, Lymphocytic, Chronic, B-Cell - Lymphoma, B-Cell
1 Location available
- Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Conditions: Leukemia
1 Location available
- Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
Conditions: Burkitt's Lymphoma - Burkitt'S-like Lymphoma
1 Location available
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
88 Locations available
- Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
24 Locations available
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
191 Locations available
- Cord Blood Expansion on Mesenchymal Stem Cells
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL - Lymphoma, Non-Hodgkin - Lymphoma, B-Cell - Lymphoma, Follicular - Lymphoma, Intermediate-Grade - Lymphoma, Large-Cell - Lymphoma, Low-Grade - Lymphoma, Mixed-Cell - Lymphoma, Small-Cell - Leukemia, Lymphocytic, Chronic - Leukemia, B-Cell, Chronic -
4 Locations available
- Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating P
Conditions: Graft Versus Host Disease - Leukemia - Lymphoma
1 Location available
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Conditions: Breast Neoplasms - Ovarian Neoplasms - Colonic Neoplasms - Prostatic Neoplasms - Uterine Cervical Neoplasms - Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
Conditions: Acute Myeloid Leukemia
1 Location available
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Pat
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute
1 Location available
- A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
Conditions: Cancer - Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matche
Conditions: Acute Myeloid Leukemia - Advanced Myelodysplastic Syndromes
1 Location available
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
149 Locations available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Trans
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Acute Lymphocytic Leukemia - Relapsed/Refractory Chronic Lymphocytic Leukemia - Relapsed/Refractory Non Hodgkin's Lymphoma - Hodgkins Disease - Relapsed Refractory Multiple Myeloma
2 Locations available
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol S
1 Location available
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
140 Locations available
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
4 Locations available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in T
Conditions: Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
214 Locations available
- Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Conditions: Lymphoma - Leukemia - Multiple Myeloma - Lymphoid Malignancies
1 Location available
- Combination Chemotherapy Followed By Donor Umbilical Cord Blood Transplant in Treating Infants With High-Risk Acute Leukemia or Myelodysplastic Syndro
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- AZD2171 in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: Leukemia - Myelodysplastic Syndromes
6 Locations available
- Study Looking at Effectiveness of I-131-Tositumomab (Bexxar) Consolidation for Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic L
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
2 Locations available
- Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Conditions: Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acu
Conditions: Myelodysplastic Syndromes (MDS) - Chronic Myelomonocytic Leukemia (CMML) - Acute Myelogenous Leukemia (AML)
17 Locations available
- Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Re
Conditions: Leukemia
1 Location available
- A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Conditions: T-Cell Lymphomas - T-Cell Leukemia - Sezary Syndrome - Mycosis Fungoides
1 Location available
- T-cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Under
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
3 Locations available
- Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia
3 Locations available
- Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
Conditions: Chronic Lymphocytic Leukemia
6 Locations available
- Intensity-Modulated Radiation Therapy, Fludarabine, and Melphalan Followed by a Donor Stem Cell Transplant in Treating Patients With Hematological Can
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
Conditions: Leukemia - Lymphoma
1 Location available
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
176 Locations available
- A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoid - Myelodysplastic Syndromes - Leukemia, Myelogenous, Chronic
1 Location available
- A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia
Conditions: Hairy Cell Leukemia
1 Location available
- Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
Conditions: Hodgkin's Disease - Non Hodgkin's Lymphoma - Myeloma - Leukemia - Myelodysplasia
1 Location available
- Anti-CD45 Monoclonal Antibody, Cytarabine, Cyclophosphamide, and Total-Body Irradiation With or Without Alemtuzumab in Treating Patients Undergoing a
Conditions: Leukemia - Myelodysplastic Syndromes
2 Locations available
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML) - Myelodysplastic Syndrome (MDS)
1 Location available
- Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
Conditions: Leukemia
1 Location available
- Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Conditions: Refractory Solid Tumors - Leukemia
1 Location available
- A Phase II Study of Umbilical Cord Blood Transplantation
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Aplastic Anemia
1 Location available
- Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
7 Locations available
- A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
Conditions: Brain Tumors - Leukemia - Sarcomas - Neuroblastoma - Lymphoma - Hodgkins Disease
1 Location available
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
4 Locations available
- Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lympho
Conditions: Leukemia - Lymphoma
2 Locations available
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
308 Locations available
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Dis
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
1 Location available
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
140 Locations available
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
4 Locations available
- Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
Conditions: Leukemia, Myelogenous, Chronic
1 Location available
- Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia - Lymphoma, Lymphoblastic
2 Locations available
- Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrom
Conditions: Atypical Chronic Myeloid Leukemia, BCR-ABL Negative - Childhood Myelodysplastic Syndromes - Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Essential Thrombocythemia - Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable - Phi
2 Locations available
- Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - AML
1 Location available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
130 Locations available
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
196 Locations available
- Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Conditions: Leukemia, Myeloid - Leukemia - Acute Myeloid Leukemia (AML)
5 Locations available
- A Combination of Imatinib Mesylate and Pegylated Interferon α2a in Chronic-Phase Chronic Myeloid Leukemia
Conditions: Chronic Myeloid Leukemia
1 Location available
- Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
Conditions: Leukemia - Cancer - Lymphoma
2 Locations available
- ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggres
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes
1 Location available
- Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
1 Location available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma - Plasma Cell Leukemia
5 Locations available
- Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Conditions: Stem Cell Transplantation - Leukemia - Lymphoma
1 Location available
- Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoblastic, Acute - Leukemia, Myelocytic, Chronic
1 Location available
- Sitagliptin Umbilical Cord Blood Transplant Study
Conditions: Leukemia, Myeloid, Acute - Acute Lymphoblastic Leukemia - Myelodysplasia - Leukemia, Myelogenous, Chronic - Lymphoma, Non-Hodgkin
1 Location available
- Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refracto
Conditions: Chronic Lymphocytic Leukemia
5 Locations available
- Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Conditions: Leukemia - Non-melanomatous Skin Cancer
3 Locations available
- Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies
Conditions: Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia - Myelodysplasia - Chronic Myeloid Leukemia
1 Location available
- T-Lymphocytes in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Leukemia - Lymphoma
3 Locations available
- Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malig Who Relapse/Progress After Rituximab
Conditions: Lymphocytic Leukemia - Mantle Cell Lymphoma
1 Location available
- Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Conditions: Non-Hodgkin's Lymphoma - Leukemia - Multiple Myeloma - Myeloproliferative Disorder
1 Location available
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CON
Conditions: B-cell Chronic Lymphocytic Leukemia
29 Locations available
- Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Conditions: Chronic Myelogenous Leukemia
1 Location available
- A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia - Leukemia
1 Location available
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
82 Locations available
- Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelocytic Leukemia - Acute Lymphocytic Leukemia - Chronic Myelocytic Leukemia - Chronic Lymphocytic Leukemia - Myelodysplastic Syndromes
1 Location available
- Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
Conditions: Lymphoblastic Leukemia - Lymphoblastic Lymphoma
1 Location available
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
138 Locations available
- Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Conditions: Adult T-Cell Leukemia (ATL)
1 Location available
- Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
46 Locations available
- Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Conditions: Hematologic Diseases - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia
1 Location available
- Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Conditions: Acute Myeloid Leukemia - Hematological Malignancies
3 Locations available
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
138 Locations available
- Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
Conditions: Multiple Myeloma - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Non Hodgkin's Lymphoma - Waldenstroms - Mantle Cell Lymphoma
1 Location available
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
3 Locations available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
2 Locations available
- Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycop
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Ad
3 Locations available
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Leukemia
94 Locations available
- Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Stem Cell Transplantation - Leukemia
1 Location available
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
Conditions: Stem Cell Transplantation - Leukemia
1 Location available
- Targeted, Dose-Escalated Intravenous Busulfan and Bolus Etoposide as Preparative Therapy for Patients With Acute Myeloid Leukemia Undergoing Autologou
Conditions: Acute Myelogenous Leukemia
1 Location available
- A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
1 Location available
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
1 Location available
- A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Conditions: Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia
3 Locations available
- DT2219ARL Immunotoxin in Treating Patients With B-Cell Leukemia or Lymphoma That Has Relapsed or Not Responded to Treatment
Conditions: Leukemia - Lymphoma
3 Locations available
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Plasma Cell Neoplasm - Myelodysplastic Syndromes
4 Locations available
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
Conditions: Leukemia, Lymphocytic, Acute
1 Location available
- Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
Conditions: Hairy Cell Leukemia
1 Location available
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
2 Locations available
- CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Conditions: Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
3 Locations available
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
1 Location available
- Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Conditions: Leukemia
69 Locations available
- LBH589 Plus Decitabine for Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma - Chronic Lymphocytic Leukemia
3 Locations available
- Unrelated Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
5 Locations available
- Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia
Conditions: WT1-positive Acute Myeloid Leukemia - Leukaemia, Myelocytic, Acute
6 Locations available
- Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Other Hematological Disorders - Metabolic Storage Diseases
17 Locations available
- Treosulfan, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Donor Umbilical Cord Blood Trans
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
3 Locations available
- Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder
1 Location available
- Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)
Conditions: Myelodysplastic Syndrome
1 Location available
- Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
Conditions: Leukemia - Lymphoma, Non-Hodgkin - Hodgkin Disease - Myelodysplastic Syndromes - Multiple Myeloma
1 Location available
- Decitabine, Vorinostat, and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma That Has Relapse
Conditions: Leukemia - Lymphoma
1 Location available
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Infantile Leukemia (Both AML and ALL) - Myelodysplastic Syndrome - Myelodysplastic/Myeloproliferative Neoplasms - Biphenotypic Leukemia
1 Location available
- Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Conditions: Acute Myelogenous Leukemia - Leukemia
1 Location available
- CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
Conditions: Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
4 Locations available
- The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Non-Hodgkins Lymphoma - Sarcoma - Neuroblastoma
5 Locations available
- Oral Clofarabine for Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
113 Locations available
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - Leukemia
1 Location available
- Clofarabine and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes That Have Relapsed or Not Res
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Adult Acute Myeloid Leukemia With t(8;21)(
1 Location available
- Multi-Virus-Specific Cytotoxic T Lymphocytes (CTLs)
Conditions: Acute Lymphoblastic Leukemia
2 Locations available
- Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leuk
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adu
3 Locations available
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
97 Locations available
- Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Conditions: Leukemia - Lymphoma
1 Location available
- Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain
Conditions: Lymphoma - Myeloma - Leukemia
2 Locations available
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
156 Locations available
- Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML
Conditions: Advanced Myelodysplastic Syndrome - Thrombocytopenia - de Novo AML - Secondary Acute Myeloid Leukemia After MDS - Myelodysplastic Syndrome
10 Locations available
- Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Tri
Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL)
23 Locations available
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Adult Acute Lymphoblastic Leukemia - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associate
3 Locations available
- Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Conditions: Leukemia-relapsed or Refractory - Cancer
13 Locations available
- JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia
Conditions: Leukemia
1 Location available
- A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic
Conditions: Lymphoma, Mantle-Cell - Leukemia, Lymphocytic, Chronic, B-Cell - Leukemia, Hairy Cell - Waldenstrom Macroglobulinemia - Multiple Myeloma
1 Location available
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Conditions: Leukemia
100 Locations available
- A Trial In Patients With Advanced Cancer And Leukemia
Conditions: Neoplasms by Histologic Type - Leukemia, Lymphoid - Leukemia, T-Cell - Solid Tumors
6 Locations available
- Vorinostat, Gemtuzumab Ozogamicin, and Azacitidine in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Leukemia
3 Locations available
- Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated W
Conditions: Leukemia
1 Location available
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
160 Locations available
- Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Conditions: Leukemia
1 Location available
- Natural History Study of Monoclonal B Cell Lymphocytosis and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: B-Cell Chronic Lymphocytic Leukemia - Monoclonal B-Cell Lymphocytosis - Lymhoma, Small Lymphocytic - Chronic Lymphocytic Leukemia
1 Location available
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Conditions: Graft Versus Host Disease - Recurrent Adult Acute Lymphoblastic Leukemia
2 Locations available
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refracto
Conditions: Leukemia - Lymphoma - Unspecified Childhood Solid Tumor, Protocol Specific
18 Locations available
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukem
Conditions: Leukemia - Non-Hodgkins Lymphoma - Hodgkins Lymphoma - MDS - Multiple Myeloma
1 Location available
- Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
24 Locations available
- 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Adult Acute Myeloid Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Recurrent Adult Acute Myeloid Leukemia - Secondary Acute Myeloid Leukemia - Secondary Myelodysplastic Syndromes - Untreated Adult Acute Myelo
1 Location available
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Testicular Germ Cell Tumor
1 Location available
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute
1 Location available
- Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
Conditions: Acute Myelogenous Leukemia - AML
1 Location available
|